Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
ABIST, 12% Decrease in Ordinary Profit for The Current Fiscal Year
6087 ABIST Co.,Ltd. 【J-GAAP】
Earnings ReportABIST Co.,Ltd. <6087> [TSE Std] announced its financial results at noon (11:30) on December 30th. The ordinary profit (non-consolidated) for the fiscal year ending September 2024 increased 22.0% from the previous period to 905 million yen. However, for the fiscal year ending September 2025, the profit is expected to decrease by 11.6% from the previous period to 800 million yen.
In the most recent three-month period, from July to September (4Q), the ordinary profit decreased to 142 million yen, a 22.0% decrease compared to the same period last year. The operating profit margin worsened from 7.3% in the same period last year to 5.5%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Sep, 2022 | 9,362 | 735 | 737 | 295 | 91.5 | 102 | Nov 9, 2022 | J-GAAP |
Sep, 2023 | 9,508 | 732 | 742 | 729 | 183.2 | 102 | Nov 10, 2023 | J-GAAP |
Sep, 2024 | 10,002 | 903 | 905 | 611 | 153.6 | 102 | Dec 30, 2024 | J-GAAP |
YoY | +5.2% | +23.4% | +22.0% | -16.2% | -16.2% |
Full Year Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Sep, 2024 Guidance | 10,100 | 710 | 710 | 590 | 148.3 | 102 | Nov 10, 2023 | J-GAAP |
Sep, 2024 Results | 10,002 | 903 | 905 | 611 | 153.6 | 102 | Dec 30, 2024 | J-GAAP |
Revision Rate | -1.0% | +27.2% | +27.5% | +3.6% | +3.6% |
Current Period Guidance
H1 Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 4,900 | 514 | 515 | 302 | 75.9 | 0 | May 15, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | ー | ー | ー | ー | - | 0 | Dec 30, 2024 | J-GAAP |
YoY | - | - | - | - | - |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Sep, 2023 | 9,508 | 732 | 742 | 729 | 183.2 | 102 | Nov 10, 2023 | J-GAAP |
Sep, 2024 | 10,002 | 903 | 905 | 611 | 153.6 | 102 | Dec 30, 2024 | J-GAAP |
Sep, 2025 Guidance | 10,700 | 800 | 800 | 440 | 110.6 | 102 | Dec 30, 2024 | J-GAAP |
YoY | +7.0% | -11.4% | -11.6% | -28.0% | -28.0% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jul - Sep, 2023 | 2,460 | 180 | 182 | 129 | 32.4 | 7.3 | Nov 10, 2023 | J-GAAP |
Oct - Dec, 2023 | 2,483 | 319 | 320 | 203 | 51.1 | 12.8 | Feb 14, 2024 | J-GAAP |
Jan - Mar, 2024 | 2,417 | 195 | 195 | 99 | 24.9 | 8.1 | May 15, 2024 | J-GAAP |
Apr - Jun, 2024 | 2,530 | 247 | 248 | 215 | 54.1 | 9.8 | Aug 9, 2024 | J-GAAP |
Jul - Sep, 2024 | 2,572 | 142 | 142 | 94 | 23.6 | 5.5 | Dec 30, 2024 | J-GAAP |
YoY | +4.6% | -21.1% | -22.0% | -27.1% | -27.1% |
Related Articles
HIDAY HIDAKA, Mar-Nov (Cumulative 3Q) Ordinary Profit Increases by 9%, Sep-Nov Ordinary Profit Increases by 7%
Nikkei 225 open on the 6th = 50 yen higher, 39,945 yen
AMIYAKI TEI, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 38%, Oct-Dec Ordinary Profit Increases by 31%
Solasia Pharma, Last Fiscal Year Net Income Loss to Narrow
Nikkei 225 close on the 30th = falling for the first time in 4 days, 386 yen lower to 39,894 yen
Nikkei 225 open on the 30th = 44 yen higher, 40,325 yen
The Nikkei 225 recovered to 40,000 yen level for the first time in a half month
Nikkei 225 close on the 27th = rising for the 3 days in a row, 713 yen higher to 40,281 yen
Solasia Pharma, The Current Fiscal Year Net Income Loss Widened in Downward Revision
KITAKEI, 0.4% Increase in Ordinary Profit for The Current Fiscal Year